文献速递生殖医学产科

中国多囊卵巢综合征患者接受与未接受抗雄激素预处理的不良妊娠结局风险比较

Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
PubMed 文献 · Fertil Steril · 2018-03-07

B组妊娠期糖尿病、妊娠期高血压和早产发生率均高于A组和C组,校正后B组上述风险仍高于健康女性,C组未见风险增加。

要点

  • 未预处理PCOS患者妊娠期糖尿病、妊娠期高血压和早产发生率均高于健康孕妇和预处理PCOS患者。
  • 校正年龄、孕前BMI、教育程度和就业状态后,未预处理PCOS患者妊娠期糖尿病风险仍升高(aOR=1.666)。
  • 接受3个月EE/CPA预处理的PCOS患者未见妊娠期糖尿病、妊娠期高血压和早产风险增加。

核心结论

  • 在该高度选择的研究人群中,PCOS患者更易发生妊娠期糖尿病、妊娠期高血压和早产。
  • EE/CPA预处理与妊娠期糖尿病、妊娠期高血压和早产风险降低相关。

研究设计与样本

  • 回顾性研究,在医科大学开展。
  • 所有PCOS患者均有生化和/或临床高雄激素血症,并在3个月经周期氯米芬促排卵内妊娠。

主要发现

  • 妊娠期糖尿病发生率:A组21.2% vs B组35.0% vs C组22.5%。
  • 妊娠期高血压发生率:A组6.5% vs B组14.1% vs C组7.7%。
  • 早产发生率:A组5.4% vs B组8.6% vs C组6.8%。
  • 新生儿出生体重各组间无显著差异。
  • 校正年龄、孕前体重指数、教育程度和就业状态后,与健康女性相比,未预处理PCOS患者妊娠期糖尿病风险升高(aOR=1.666;95%CI 1.340-2.072),妊娠期高血压风险升高(aOR=1.487;95%CI 1.093-2.023),早产风险升高(aOR=1.522;95%CI 1.051-2.205);C组未见风险增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the prevalence of adverse pregnancy outcomes in healthy Chinese women and to investigate whether these outcomes could be decreased in patients with polycystic ovary syndrome (PCOS) by ethinylestradiol/cyproterone acetate (EE/CPA) pretreatment. DESIGN: Retrospective study. SETTING: Medical university. PATIENT(S): Six thousand healthy women (group A) were selected from 24,566 pregnant women by randomized sampling. Four hundred forty-eight patients with PCOS without EE/CPA pretreatment were assigned to group B, and 222 patients with PCOS with 3 months of pretreatment to group C. All patients with PCOS had biochemical and/or clinical hyperandrogenism and conceived within 3 monthly ovulation inductions using clomiphene. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Gestational diabetes mellitus (GDM), pregnancy-induced hypertension (PIH), premature delivery (PD), and neonatal birth weight. RESULT(S): The prevalence of GDM, PIH, and PD was higher in group B than in groups A and C (A vs. B vs. C: GDM, 21.2% vs. 35.0% vs. 22.5%; PIH, 6.5% vs. 14.1% vs. 7.7%; PD, 5.4% vs. 8.6% vs. 6.8%). No significant difference was found in neonatal birth weight. After adjusting for age, pregestational body mass index, education level, and employment status, PCOS without pretreatment increased the risk of GDM (adjusted odds ratio [aOR] = 1.666; 95% confidence interval [CI], 1.340-2.072), PIH (aOR = 1.487; 95% CI, 1.093-2.023), and PD (aOR = 1.522; 95% CI 1.051-2.205), compared with healthy women. No increased risk was found in group C. CONCLUSION(S): In our highly selected study population, patients with PCOS are more likely to develop GDM, PIH, and PD. Pretreatment with EE/CPA was associated with a lower risk of GDM, PIH, and PD.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Li Y, Ruan X, Wang H, et al. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment. Fertil Steril. 2018. PMID: 29525688. doi:10.1016/j.fertnstert.2017.12.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。